Rhythm Pharmaceuticals, Inc.
RYTM
$93.72
$2.412.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 340.63M | 388.95M | 416.05M | 291.03M | 314.49M |
| Total Receivables | 34.19M | 26.08M | 33.03M | 26.12M | 17.83M |
| Inventory | 28.65M | 25.75M | 22.11M | 18.87M | 19.32M |
| Prepaid Expenses | 26.62M | -- | 23.61M | 24.66M | 17.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 26.13M | -- | -- | -- |
| Total Current Assets | 430.09M | 466.92M | 494.80M | 360.68M | 369.29M |
|
|
|||||
| Total Current Assets | 430.09M | 466.92M | 494.80M | 360.68M | 369.29M |
| Net Property, Plant & Equipment | 4.00M | 4.15M | 3.40M | 3.56M | 3.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.11M | 5.32M | 5.53M | 5.75M | 5.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.12M | 3.81M | 3.14M | 2.75M | 7.61M |
| Total Assets | 442.32M | 480.20M | 506.87M | 372.73M | 386.69M |
|
|
|||||
| Total Accounts Payable | 12.30M | 13.95M | 13.63M | 15.98M | 11.91M |
| Total Accrued Expenses | 74.90M | 79.78M | 81.06M | 64.81M | 53.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.81M | 7.95M | 6.18M | 4.29M | 1.81M |
| Total Finance Division Other Current Liabilities | 5.19M | 4.27M | 3.40M | 44.38M | 44.58M |
| Total Other Current Liabilities | 5.19M | 4.27M | 3.40M | 44.38M | 44.58M |
| Total Current Liabilities | 103.20M | 105.94M | 104.27M | 129.46M | 111.82M |
|
|
|||||
| Total Current Liabilities | 103.20M | 105.94M | 104.27M | 129.46M | 111.82M |
| Long-Term Debt | 98.34M | 100.89M | 103.41M | 106.01M | 107.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.16M | 3.34M | 3.52M | 3.68M | 3.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 204.70M | 210.17M | 211.19M | 239.15M | 223.60M |
|
|
|||||
| Common Stock & APIC | 1.53B | 1.49B | 1.45B | 1.24B | 1.22B |
| Retained Earnings | -1.41B | -1.35B | -1.30B | -1.25B | -1.20B |
| Treasury Stock & Other | 444.00K | -796.00K | -926.00K | -2.25M | -51.00K |
| Total Common Equity | 122.91M | 139.07M | 148.82M | -11.91M | 18.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 114.71M | 130.96M | 146.87M | 145.49M | 144.14M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 114.71M | 130.96M | 146.87M | 145.49M | 144.14M |
|
|
|||||
| Total Common Equity | 122.91M | 139.07M | 148.82M | -11.91M | 18.95M |
| Total Preferred Equity | 114.71M | 130.96M | 146.87M | 145.49M | 144.14M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 237.62M | 270.03M | 295.68M | 133.58M | 163.09M |
|
|
|||||